TY  - CONF

T1  - Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML

JO  - Blood

PY  - 2018/11/29

AU  - O'Brien S

AU  - Cork L

AU  - Bandeira V

AU  - Bescoby R

AU  - Foroni L

AU  - Alaily L

AU  - Osborne W

AU  - Bell-Gorrod H

AU  - Latimer N

AU  - Apperley J

AU  - Hedgley C et al

ED  - 

DO  - DOI: 10.1182/blood-2018-99-110128

PB  - American Society of Hematology

VL  - 132

IS  - Supplement 1

SP  - 457

EP  - 457

Y2  - 2024/12/22

ER  -